Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their M… (NCT06959810) | Clinical Trial Compass
RecruitingNot Applicable
Impact of Adapted Aesthetic Onco in Patients With Upper Aerodigestive Tract Cancer During Their Management
France55 participantsStarted 2025-10-24
Plain-language summary
Treatment for cancers of the pharyngolarynx is mutilating, with major consequences for patients' lives in terms of physical and functional after-effects. The psycho-social consequences are also significant, notably the metamorphosis of identity linked to the disease and its treatment, which alters the patient's self-image.
Initial feedback from patients who have been able to benefit from adapted oncoesthetics (OEA) is overwhelmingly positive.
This study will assess the feasibility of oncoesthetics and describe any obstacles.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patient aged 18 or over
* Neoplastic location: oropharynx, oral cavity, hypopharynx, larynx, nasal cavity, salivary glands, cavum, sinus.
* Patient due to start oncological treatment (recurrence authorized)
* Patient fluent in French.
* Affiliation with a social security scheme
* Signature of informed consent prior to any specific procedure linked to the study
* Treatment with curative intent
Exclusion Criteria:
* Breast-feeding or pregnant patient
* Any associated medical or psychological condition that could compromise the patient's ability to participate in the study
* Patient deprived of liberty, under guardianship, or subject to a legal protection measure or unable to express their consent.
* Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evaluate, in patients treated for cancer of the upper aerodigestive tract, the impact of early treatment with Adapted Onco-Esthetics
Timeframe: At each session (first , second and third). An interval of one to 4 weeks between 2 sessions is permitted